ID: ALA3244855

Max Phase: Preclinical

Molecular Formula: C25H29N5O6

Molecular Weight: 495.54

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCOC(=O)CC[C@H](NC(=O)c1ccc(NCc2ccc3nc(N)nc(O)c3c2)cc1)C(=O)OCC

Standard InChI:  InChI=1S/C25H29N5O6/c1-3-35-21(31)12-11-20(24(34)36-4-2)28-22(32)16-6-8-17(9-7-16)27-14-15-5-10-19-18(13-15)23(33)30-25(26)29-19/h5-10,13,20,27H,3-4,11-12,14H2,1-2H3,(H,28,32)(H3,26,29,30,33)/t20-/m0/s1

Standard InChI Key:  NWZJUTQVCVCWMY-FQEVSTJZSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 495.54

Molecular Weight (Monoisotopic): 495.2118

AlogP: 2.53

#Rotatable Bonds: 11

Polar Surface Area: 165.76

Molecular Species: NEUTRAL

HBA: 10

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 11

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.47

CX Basic pKa: 3.13

CX LogP: 2.54

CX LogD: 2.54

Aromatic Rings: 3

Heavy Atoms: 36

QED Weighted: 0.29

Np Likeness Score: -0.80

References

1. Hynes JB, Eason DE, Garrett CM, Colvin PL..  (1977)  Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.,  20  (4): [PMID:850245] [10.1021/jm00214a030]

Source

Source(1):

• Scientific Literature